Tonix Pharmaceuticals Holding Corp. Company Profile (NASDAQ:TNXP)

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TNXP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.70
  • 50 Day Moving Average: $1.63
  • 200 Day Moving Average: $2.17
  • 52-Week Range: $0.69 - $7.95
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.61
  • P/E Growth: 0.00
  • Market Cap: $18.10M
  • Outstanding Shares: 25,860,000
  • Beta: 2.61
Profitability:
  • Return on Equity: -131.74%
  • Return on Assets: -116.12%
Debt:
  • Current Ratio: 8.03%
  • Quick Ratio: 8.03%
Additional Links:
Companies Related to Tonix Pharmaceuticals Holding Corp.:

Analyst Ratings

Consensus Ratings for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $8.67 (1,138.10% upside)

Analysts' Ratings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Show:
DateFirmActionRatingPrice TargetDetails
9/7/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
9/7/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
9/7/2016Cantor FitzgeraldDowngradeBuy -> HoldView Rating Details
6/30/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/8/2016Q2($0.55)($0.50)ViewN/AView Earnings Details
5/9/2016Q1($0.63)($0.74)ViewN/AView Earnings Details
3/4/2016Q4($0.66)($0.71)ViewN/AView Earnings Details
8/10/2015Q215($0.65)($0.73)ViewN/AView Earnings Details
5/11/2015Q115($0.54)($0.71)ViewN/AView Earnings Details
3/3/2015Q414($0.81)($0.83)ViewN/AView Earnings Details
11/10/2014Q314($0.69)($0.71)ViewN/AView Earnings Details
8/8/2014Q214($0.53)($0.61)ViewN/AView Earnings Details
5/13/2014Q114($0.35)($0.59)ViewN/AView Earnings Details
3/31/2014($0.46)($0.74)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.15 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.58)($0.58)($0.58)
Q2 20163($0.63)($0.49)($0.56)
Q3 20163($0.39)($0.30)($0.34)
Q4 20163($0.35)($0.15)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 33.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016Ernest MarioDirectorBuy100,000$0.79$79,000.00View SEC Filing  
6/22/2016Seth LedermanCEOBuy20,000$2.08$41,600.00View SEC Filing  
6/21/2016Bradley SaengerCFOBuy2,000$2.00$4,000.00View SEC Filing  
6/21/2016Bruce DaughertyInsiderBuy100,000$2.00$200,000.00View SEC Filing  
6/21/2016John B RhodesDirectorBuy25,000$2.00$50,000.00View SEC Filing  
6/3/2016Gregory M SullivanInsiderBuy20,000$2.50$50,000.00View SEC Filing  
5/12/2016Ernest MarioDirectorBuy31,042$2.30$71,396.60View SEC Filing  
5/11/2016Ernest MarioDirectorBuy8,210$2.24$18,390.40View SEC Filing  
3/23/2016Seth LedermanCEOBuy8,000$2.44$19,520.00View SEC Filing  
3/16/2016Ernest MarioDirectorBuy75,000$2.29$171,750.00View SEC Filing  
9/30/2015Gregory M SullivanInsiderBuy5,000$5.18$25,900.00View SEC Filing  
9/28/2015Gregory M SullivanInsiderBuy4,694$5.95$27,929.30View SEC Filing  
9/25/2015Seth LedermanCEOBuy6,000$6.50$39,000.00View SEC Filing  
8/26/2015Ernest MarioDirectorBuy10,000$6.05$60,500.00View SEC Filing  
8/25/2015Ernest MarioDirectorBuy1,468$6.40$9,395.20View SEC Filing  
8/24/2015Ernest MarioDirectorBuy2,532$6.20$15,698.40View SEC Filing  
8/20/2015Ernest MarioDirectorBuy6,000$6.64$39,840.00View SEC Filing  
8/17/2015Ernest MarioDirectorBuy15,000$6.93$103,950.00View SEC Filing  
7/17/2015John B RhodesDirectorBuy6,000$7.50$45,000.00View SEC Filing  
7/17/2015Leland GershellCFOBuy1,000$7.50$7,500.00View SEC Filing  
6/11/2015Gregory M SullivanInsiderBuy4,500$8.38$37,710.00View SEC Filing  
3/17/2015Seth LedermanCEOBuy2,000$7.02$14,040.00View SEC Filing  
3/13/2015Seth LedermanCEOBuy2,000$7.24$14,480.00View SEC Filing  
3/11/2015Seth LedermanCEOBuy2,000$6.95$13,900.00View SEC Filing  
3/10/2015Charles E Iv MatherDirectorBuy1,000$6.80$6,800.00View SEC Filing  
3/9/2015Seth LedermanCEOBuy2,000$6.48$12,960.00View SEC Filing  
3/6/2015Ernest MarioDirectorBuy4,000$6.57$26,280.00View SEC Filing  
3/5/2015Seth LedermanCEOBuy2,000$6.27$12,540.00View SEC Filing  
2/9/2015Ernest MarioDirectorBuy30,000$5.85$175,500.00View SEC Filing  
2/9/2015Leland GershellCFOBuy5,000$5.85$29,250.00View SEC Filing  
9/27/2013Charles E Iv MatherDirectorBuy1,000$3.65$3,650.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateHeadline
finance.yahoo.com logoTonix Pharmaceuticals to Present at 16th Annual Sachs Biotech in Europe Forum (NASDAQ:TNXP)
finance.yahoo.com - September 26 at 10:47 AM
News IconReviewing Overselling Stock: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post Registrar (NASDAQ:TNXP)
postregistrar.com - September 20 at 4:30 PM
4-traders.com logoTONIX PHARMACEUTICALS HOLDING CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:TNXP)
www.4-traders.com - September 19 at 7:38 PM
News IconTonix Pharmaceuticals Holding Corp. (TNXP) – Research Analysts ... - DailyQuint (NASDAQ:TNXP)
dailyquint.com - September 19 at 9:31 AM
biz.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:TNXP)
biz.yahoo.com - September 19 at 9:31 AM
News IconInsider Trading Review: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - The Voice Registrar (NASDAQ:TNXP)
voiceregistrar.com - September 16 at 7:26 PM
News IconStock Perspective: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Company Earnings Watch - Frisco Fastball (NASDAQ:TNXP)
friscofastball.com - September 15 at 11:26 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): A Potential ... - Street Register (NASDAQ:TNXP)
streetregister.com - September 15 at 11:26 AM
News IconAnalysts Place Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Under the Lens of the Microscope - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - September 12 at 9:40 AM
News IconOverselling Stock in Limelight: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post Registrar (NASDAQ:TNXP)
postregistrar.com - September 10 at 6:49 PM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) & Calpine Corporation (NYSE:CPN) UPDATE ON U.S ... - Money News (NASDAQ:TNXP)
www.newsismoney.com - September 9 at 9:27 AM
News IconMost recent Trading report: Tonix Pharmaceuticals Holding Corp.'s (TNXP) (NASDAQ:TNXP)
www.crcconnection.com - September 8 at 11:36 AM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) , DaVita healthCare Partners Inc (NASDAQ:TNXP)
magseriesusa.net - September 8 at 11:36 AM
thestreet.com logoTonix Pharmaceuticals To Present At Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:TNXP)
www.thestreet.com - September 7 at 7:50 PM
News IconTonix Pharmaceuticals Shares Plummet 50% On Phase 3 Trial Failure (NASDAQ:TNXP)
www.talkmarkets.com - September 7 at 7:50 PM
investors.com logoTonix Pharma shares halve after Phase 3 flop (NASDAQ:TNXP)
www.proactiveinvestors.com - September 7 at 7:50 PM
News IconShares Trading Lower in Today's Session: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - September 6 at 7:50 PM
News IconShares Gapping Lower Before the Open: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - September 6 at 7:50 PM
smarteranalyst.com logoStock Update (NASDAQ:TNXP): Tonix Pharmaceuticals Holding Corp. Reports Topline Results from Phase 3 AFFIRM ... - Smarter Analyst (NASDAQ:TNXP)
www.smarteranalyst.com - September 6 at 7:50 PM
finance.yahoo.com logoREUTERS AMERICA NEWS PLAN FOR TUESDAY SEPT 6 (NASDAQ:TNXP)
finance.yahoo.com - September 6 at 7:50 PM
finance.yahoo.com logoTNXP: AFFIRM Study Does Not Meet Primary Endpoint; Company to Focus on Development of TNX-102 SL in PTSD (NASDAQ:TNXP)
finance.yahoo.com - September 6 at 7:50 PM
247wallst.com logoWhy This Major Disappointment May Not Mark the End for Tonix Pharmaceuticals (NASDAQ:TNXP)
247wallst.com - September 6 at 7:50 PM
reuters.com logoTonix to stop testing drug for fibromyalgia, shares plunge (NASDAQ:TNXP)
www.reuters.com - September 6 at 9:26 AM
streetinsider.com logoForm 8-K Tonix Pharmaceuticals For: Sep 06 (NASDAQ:TNXP)
www.streetinsider.com - September 6 at 9:26 AM
seekingalpha.com logoTonix Pharma's lead product candidate TNX-102 SL flunks late-stage study in fibromyalgia; shares slump 16% premarket (NASDAQ:TNXP)
seekingalpha.com - September 6 at 9:26 AM
nasdaq.com logoTonix Says AFFIRM Data Didn''t Achieve Primary Efficacy Endpoint; Stock Down (NASDAQ:TNXP)
www.nasdaq.com - September 6 at 9:26 AM
globenewswire.com logoTonix Pharmaceuticals Reports Topline Results from Phase 3 AFFIRM Study of TNX-102 SL in Fibromyalgia and Provides Corporate Update (NASDAQ:TNXP)
www.globenewswire.com - September 6 at 9:26 AM
finance.yahoo.com logoTonix says to stop testing pain disorder drug (NASDAQ:TNXP)
finance.yahoo.com - September 6 at 9:26 AM
News IconStock Down in Trading Session: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - September 1 at 7:42 PM
News IconTonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Secures FDA Green Light - Scibility Media (NASDAQ:TNXP)
scibilitymedia.com - August 31 at 9:54 AM
News IconActive Runners: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Amgen, Inc. (NASDAQ:AMGN), Flowers ... - NYSE Journal (press release) (NASDAQ:TNXP)
stockznews.com - August 30 at 7:38 PM
baystreet.ca logoTonix Pharmaceuticals Gains On Update for TNX-102 SL (NASDAQ:TNXP)
www.baystreet.ca - August 30 at 11:09 AM
streetinsider.com logoTonix Pharma (TNXP) Issues Positive Update from End-of-Phase 2/Pre-Phase 3 FDA Meeting for TNX-102 SL in PTSD (NASDAQ:TNXP)
www.streetinsider.com - August 30 at 11:09 AM
News IconShares Gapping Higher Pre-Market: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - August 29 at 7:44 PM
bidnessetc.com logoTonix Pharmaceuticals Holding Corp (TNXP) Stock Jumps as FDA Approves Phase 3 Trial for PTSD - Bidness ETC (NASDAQ:TNXP)
www.bidnessetc.com - August 29 at 7:44 PM
seekingalpha.com logoTonix Pharma up 16% premarket on advancement on TNX-102 SL in PTSD (NASDAQ:TNXP)
seekingalpha.com - August 29 at 9:47 AM
4-traders.com logoTONIX PHARMACEUTICALS HOLDING CORP. : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:TNXP)
www.4-traders.com - August 29 at 9:47 AM
globenewswire.com logoTonix Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TNX-102 SL in Post-Traumatic Stress Disorder (NASDAQ:TNXP)
globenewswire.com - August 29 at 9:47 AM
live-pr.com logoNew Market Research Report: Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial and Strategic SWOT Analysis Review (NASDAQ:TNXP)
www.live-pr.com - August 25 at 8:06 PM
News IconStocks to Watch: U.S. Auto Parts Network, Inc.(NASDAQ:PRTS), Tonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP) - NYSE Journal (press release) (NASDAQ:TNXP)
stockznews.com - August 23 at 7:59 PM
finance.yahoo.com logoTNXP: Topline Results From AFFIRM Study in Fibromyalgia in September 2016 (NASDAQ:TNXP)
finance.yahoo.com - August 23 at 7:59 PM
News IconWhat Does the Consensus Have to Say About Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Shares? - Post News (NASDAQ:TNXP)
www.kentuckypostnews.com - August 22 at 9:44 AM
investornewswire.com logoWill Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Hit $12 Price Target? - Investor Newswire (NASDAQ:TNXP)
www.investornewswire.com - August 22 at 9:44 AM
kcregister.com logoEarly Session Advancers: Ocular Therapeutix (NASDAQ:OCUL), Tonix Pharmaceuticals Holding (NASDAQ:TNXP ... - KC Register (NASDAQ:TNXP)
www.kcregister.com - August 15 at 8:12 PM
finance.yahoo.com logoTonix Pharmaceuticals Presents Poster on the Development of TNX-102 SL for Post-Traumatic Stress Disorder (PTSD) at the 2016 Military Health System Research Symposium (NASDAQ:TNXP)
finance.yahoo.com - August 15 at 9:57 AM
biz.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:TNXP)
biz.yahoo.com - August 15 at 9:57 AM
finance.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Financials (NASDAQ:TNXP)
finance.yahoo.com - August 13 at 7:23 PM
biz.yahoo.com logoTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD (NASDAQ:TNXP)
biz.yahoo.com - August 11 at 11:16 AM
smarteranalyst.com logoHere's Why Cantor Reiterates Buy on Tonix Pharmaceuticals Holding Corp. (TNXP) - Smarter Analyst (NASDAQ:TNXP)
www.smarteranalyst.com - August 10 at 8:25 PM
News IconStocks Attracts Frontline Trades- Inovio Pharmaceuticals (NASDAQ:INO), Tonix Pharmaceuticals (NASDAQ:TNXP) - Seneca Globe (NASDAQ:TNXP)
www.senecaglobe.com - August 9 at 8:11 PM

Social

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff